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Abstract
A method for measuring the microclustering of a class of cell surface receptors called integrins is reported.
Integrins are proteins involved in bidirectional signaling across the cell membrane and are important in cell
adhesion, growth, and survival. Their activity is regulated by changes in protein conformation and protein
clustering. The developed in vivo clustering assay uses fluorescence resonance energy transfer (FRET) and has
the benefit of requiring a single cloning step to generate FRET donors and acceptors that can be used to
measure the clustering of a series of integrin mutants. The FRET reporters contain extracellular donor or
acceptor fluorescent protein attached to native integrin cytoplasmic and transmembrane domains, and these
are expressed along with wild-type or mutant integrins. Expression of the FRET reporters has no affect on the
ligand binding properties of coexpressed integrins. FRET values are calculated for cell lines spreading on
ligand coated surfaces, and these values are independent of fluorescent protein expression. No FRET is
observed in cell lines expressing the reporters in the absence of integrins. Integrin-dependent FRET values
increase ∼2−3-fold when the integrins contain mutations that result in increased ligand binding affinities.
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General in Vivo Assay for the Study of Integrin Cell
Membrane Receptor Microclustering
Emily A. Smith,*,†,‡ Thomas A. Bunch,‡ and Danny L. Brower‡,§
Departments of Molecular and Cellular Biology and Biochemistry, Arizona Cancer Center, 1515 North Campbell Avenue,
Tucson, Arizona 85724, and Department of Chemistry, Iowa State University, 0706 Gilman Hall, Ames, Iowa 50011
A method for measuring the microclustering of a class of
cell surface receptors called integrins is reported. Inte-
grins are proteins involved in bidirectional signaling
across the cell membrane and are important in cell
adhesion, growth, and survival. Their activity is regulated
by changes in protein conformation and protein cluster-
ing. The developed in vivo clustering assay uses fluores-
cence resonance energy transfer (FRET) and has the
benefit of requiring a single cloning step to generate FRET
donors and acceptors that can be used to measure the
clustering of a series of integrin mutants. The FRET
reporters contain extracellular donor or acceptor fluores-
cent protein attached to native integrin cytoplasmic and
transmembrane domains, and these are expressed along
with wild-type or mutant integrins. Expression of the FRET
reporters has no affect on the ligand binding properties
of coexpressed integrins. FRET values are calculated for
cell lines spreading on ligand coated surfaces, and these
values are independent of fluorescent protein expression.
No FRET is observed in cell lines expressing the reporters
in the absence of integrins. Integrin-dependent FRET
values increase 2-3-fold when the integrins contain
mutations that result in increased ligand binding affinities.
The cell membrane contains a complex array of lipids, proteins,
carbohydrates, and small molecules, which undergo dynamic
organization into microscale and macroscale clusters. This lateral
organization varies in the time scale, as well as the length scale,
and is important in cell signaling, cell recognition, and other basic
cellular functions.1 Cell membrane proteins responsible for signal
transduction into the cell (outside-in signaling) and into the
extracellular environment (inside-out signaling) are termed recep-
tors. The integrin family of cell membrane receptors is important
to cell adhesion, mobility, growth, survival, proliferation, and
differentiation.2 Integrins are composed of noncovalently associ-
ated R and â subunits and are highly conserved from invertebrates
to mammals.
With their vital role in cell survival and growth, and their
implication in some forms of cancer,3 it is important to understand
how integrins’ activities are regulated within the cell. Probes for
measuring integrin ligand affinity exist.4-6 However, much less
is known about the macroscale and microscale dynamics of
integrin clusters within the cell membrane of living cells and
tissues. Macroscale clusters are defined as those larger than the
resolution of an optical microscope, 200 nm, while microscale
clusters cannot be observed using conventional fluorescence
microscopy. Studying integrin dynamics requires an in vivo
detection technique that minimally disturbs the cells or tissue
being studied, which precludes many techniques that could
provide microscale resolution, such as atomic force microscopy.
Previous experimental designs for elucidating microscale integrin
dynamics used fluorescent proteins attached onto the cytoplasmic
domains of the integrin R subunit.7,8 This allowed the use of
fluorescence resonance energy transfer (FRET) or biolumines-
cence resonance energy transfer to study the microclustering
properties of the receptors within the cell membrane. A similar
experimental setup, with donor and acceptor fluorescent proteins
attached to the cytoplasmic domains, has also been used to study
the separation distance between the R and â cytoplasmic tails as
the integrins undergo conformational changes.9 The attachment
of fluorescent proteins onto the amino- or carboxy-terminus of
membrane proteins for FRET assays has also been reported for
other membrane proteins.10-12 These experiments proved fruitful
in measuring the clustering properties of the membrane proteins;
however, these properties could be altered by direct attachment
of the fluorescent reporter proteins. This could affect the interac-
tions of the receptor with cytoplasmic components,13,14 alter the
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conformation of the receptor,15,16 or change its diffusion properties
through the additional mass of 26 kDa (i.e., one-sixth to one-
fourth the weight of an average integrin subunit). Finally,
analyzing protein mutants with these experimental setups requires
additional, time-consuming, cloning steps to generate the FRET
donor and acceptor constructs for each mutant. For example, a
recent screen to generate mutant integrins with altered function
generated over 50 mutants that may have altered clustering
properties.17 To study the clustering properties of these 50 mutants
with the existing methods would require 100 independent cloning
steps to generate FRET donor and acceptor constructs.
We report the development of a FRET assay that requires a
single cloning step to study the microclustering of a series of
mutant integrin proteins in vivo. The assay is used to study the
microclustering of Drosophila RPS2CâPS integrins in S2 cells. The
effects of the FRET donor and acceptor on the properties of the
integrins are studied, and the application of the developed assay
to the study of integrin mutants with enhanced ligand binding
affinities is reported. It is proposed that this method for studying
protein microclusters can be developed for other membrane
proteins and would greatly benefit our understanding of cell
membrane protein dynamics.
EXPERIMENTAL SECTION
Cell Culture. Drosophila S2 cells were cultured as described
previously.18 Cells were cotransfected with plasmids expressing
wild-type or mutant RPS2C and âPS integrin subunits and FRET
reporters or FRET controls. All constructs were under the
regulation of the heat shock 70 inducible promoter and were
coexpressed with bacterial dihydrofolate reductase selectable
marker as described previously.19 Cell lines with no integrins were
transfected with only the FRET reporters or FRET controls and
the selectable marker. Stably transformed cell lines were frozen
in several aliquots. Cell lines were used for 2 months and then
replaced with a freshly thawed aliquot due to a gradual decrease
in expression of the FRET reporters. Removal of endogenous
integrins was accomplished using RNA interference against the
myospheroid gene (Drosophila âPS integrin) as reported previ-
ously.4
Protein Constructs. Wild-type or mutant integrin constructs
have been described previously.17,19,20 The FRET donor was a
monomeric variant of the yellow fluorescent protein, venus (ìabs,max
) 515 nm; ìex,max) 528 nm),21 which was constructed using
standard molecular biology techniques to generate a V207L
mutation. The FRET acceptor was monomeric dsRED variant
cherry22 (ìabs,max ) 587 nm; ìex,max) 610 nm). FRET reporters and
FRET controls were constructed by cloning the fluorescent protein
into plasmids for the expression of the transmembrane and
cytoplasmic domains of âPS (FRET reporters) or mouse mammary
CD2 (FRET controls) using standard molecular biology tech-
niques. A serine-rich, 16-amino acid linker peptide was added
between the fluorescent proteins and the transmembrane domain.
An incorporated signal sequence ensured cell membrane expres-
sion of the FRET controls and reporters. Complete protein
sequences for the FRET controls and reporters are provided in
the Supporting Information.
Expression/Affinity Assays. The levels of RPS2C expression
were measured in each experiment and for every cell line. An
aliquot containing 5  105 cells was centrifuged and resuspended
in biotinylated RPS2C antibody (CF.2C7) in M3 medium + 12.5%
fetal calf serum for 30 min on ice, followed by addition of
phycoerythrin-labeled streptavidin for 30 min on ice. Finally, the
cells were fixed with a 4% v/v formaldehyde solution in phosphate-
buffered saline, pH 7, and analyzed by flow cytometry for
phycoerythrin fluorescence. The levels of YFP expression were
measured for each experiment in a similar fashion using green
fluorescent protein antibody (Sigma, also binds to venus) and
phycoerythrin-labeled secondary antibody. Integrin affinity for a
soluble binding ligand mimetic, TWOW-1, was measured as
previously described4 with the following modifications: (i) the cells
were not treated with collagenase/Dispase prior to the start of
the assay; (ii) the secondary antibody was phycoerythrin-labeled
goat anti-mouse IgG; (iii) MnCl2 was not used.
Preparation of Tiggrin Surfaces. Glass microscope slides
(Carlson Scientific, Peotone, IL) were sterilized in 70% ethanol
for 15 min and allowed to air-dry in a sterile environment. They
were coated with a sterile solution containing 0.5 íg/mL RBB
tiggrin23 in phosphate-buffered saline, pH 7, for 2 h. The tiggrin
solution was then removed, the slides were rinsed, and the
remaining exposed glass surface was blocked using a 10 mg/mL
solution of bovine serum albumin in phosphate-buffered saline,
pH 7. They were stored overnight at 2 °C and used within 24 h.
FRET Assay. Cells were given fresh medium 1-2 days before
each experiment. Cells were heat shocked for 30 min at 36 °C to
induce the expression of integrins and FRET reporters or controls
and allowed to recover for 4 h at 25 °C. The cells were counted,
pelleted by centrifugation, and resuspended in serum-free medium
at a density of 3  105 cells/mL. The cells were placed on a tiggrin-
coated substrate and allowed to spread for 1 h. The medium was
removed from the surface and replaced with 20 mM BES Tyrodes
buffer (137 mM NaCl, 2.9 mM KCl, 1% w/v glucose, 10 íM CaCl2,
1 mM MgCl2) to reduce the amount of background fluorescence
generated by the medium. The cells were immediately analyzed
using a Ziess Universal microscope with mercury lamp excitation
and a Zeiss Axio Cam MRm camera and Zeiss AxioVision 4
software. Three images were captured for each cell that was
analyzed: (i) venus filter set (excitation 485-nm band-pass,
emission 515-565 nm), (ii) cherry filter set (excitation 546-nm
band-pass, emission 590-nm long pass), and (iii) venus excitation
filter with cherry emission filter (FRET filters). The exposure time
for the cherry image was 2 s and for the FRET and venus images
was 10 s. The camera gain was set to 2. The S2 cells did not move
in the time it took to capture the images. Once the medium was
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replaced with the BES Tyrodes buffer, all analysis was completed
within 1 h to ensure cell viability.
Digestion of Surface Proteins. For experiments involving
protease digestion of cell surface proteins, the heat shock step in
the FRET assay was replaced by treating 1  106 cells in 1 mg/
mL Dispase/collagenase (Roche Applied Science) in Robb’s saline
lacking divalent cations (1.2 mM phosphate buffer, pH 6.75, 26
mM NaCl, 20 mM KCl, 5 mM glucose, 50 mM sucrose) at 36 °C
for 30 min. This treatment also served to induce the expression
of the integrins and FRET reporters or controls.
Analysis. Data analysis was performed using the program
ImageJ 1.34s (NIH). Reported FRET values were calculated as
described previously using the following equation:24
where IDA, IAA, and IDD are the images obtained with the FRET
filters, cherry filters, and venus filters, respectively. The constants
a, b, c, and d account for bleed through of: cherry into the FRET
filters, cherry into the venus filters, venus into the cherry filters,
and venus into the FRET filters, respectively. These values were
measured in cell lines that contained only the cherry FRET control
plus wild-type integrins (a and b) or venus FRET control plus wild-
type integrins (c and d) and were found for the conditions used
in this study to be as follows: a ) 0.248 ( 0.090; b ) 0.084 (
0.095; c ) 0.049 ( 0.056; d ) 0.148 ( 0.070. All reported FRET
values in the text have been normalized to the values obtained
for the cell line expressing wild-type integrins and the FRET
reporters. All values represent the average of three replicate
experiments, and reported errors are ( one standard deviation.
For the FRET assays, at least 100 cells were analyzed, and for
the flow cytometry experiments, 30 000 cells were analyzed.
RESULTS AND DISCUSSION
A FRET assay was developed to measure the microclustering
of wild-type and mutant integrins in vivo. A schematic showing
the general assay format is shown in Figure 1. The use of
fluorescent proteins as the FRET donor and FRET acceptor satisfy
the requirement for in vivo studies. The FRET donor was a
monomeric yellow fluorescent protein variant, mvenus. The FRET
acceptor was the monomeric version of dsRED, cherry. In order
to avoid separate cloning steps for each mutant protein to be
studied (i.e., to avoid attaching the FRET donor or FRET acceptor
onto each mutant integrin), a general FRET donor and acceptor
was developed that can cluster with wild-type or mutant integrins.
The developed assay uses donor fluorescent protein and acceptor
fluorescent protein cloned onto the transmembrane and cytoplas-
mic domains of the âPS integrin subunit (TCD-â). Hereon, the
use of the phrase FRET reporter indicates a population of TCD-â
containing the donor fluorescent protein and a separate population
of TCD-â containing the acceptor fluorescent protein. It has been
found that TCD-â in the absence of fluorescent protein localizes
in macroscale clusters with integrins when coexpressed in vivo.25
It has also been shown that the FRET reporters are observed in
macroscale integrin clusters in Drosophila S2 cells (see Supporting
Information). Therefore, it was postulated that the FRET reporters
would exhibit microscale clustering with the integrins. An ad-
ditional benefit to the proposed FRET assay is that it does not
require any alterations to the integrins, such as attaching the
donor or acceptor onto the amino- or carboxy-terminus, which
could have an effect on integrin function and integrin-protein
interactions. Finally, the FRET reporters do not contain ligand
binding domains, which would compete with the integrins for
ligand.
A set of FRET controls was also developed which were
expected to be less effective at microscale clustering with integrins
based on macroscale clustering data. The FRET controls contain
the transmembrane and cytoplasmic domain of mouse mammary
CD2 (TCD-CD2), a cell surface receptor that has no homologue
in the Drosophila proteome. It has been shown that TCD-CD2 is
not as effective as TCD-â in macroscale clustering with integrins
in vivo.25 The FRET reporters or FRET controls were coexpressed
with wild-type or mutant RPS2CâPS integrins.
The FRET reporters do not affect the integrins’ ligand binding
affinity. One ligand for RPS2CâPS integrins is an extracellular
matrix protein tiggrin, and TWOW-1 is a monomeric soluble
binding ligand mimetic for RPS2CâPS integrins. The results
shown in Table 1 were obtained using flow cytometry to measure
TWOW-1 binding to seven cell lines expressing wild-type or
mutant integrins with or without FRET reporters or controls. All
the results are normalized to the cell line expressing wild-type
integrins in the absence of FRET reporters or FRET controls (Râ).
The cell line expressing wild-type integrins and the FRET
reporters (TCD-â; Râ) shows essentially no change in TWOW-1
binding compared to the cell line expressing only the wild-type
integrins. The FRET controls also show no affect on the binding
of wild-type integrins to TWOW-1 (TCD-CD2; Râ). There is
minimal change in TWOW-1 binding for cell lines with and without
the FRET reporters when the integrins have an R cytoplasmic
mutation (GFFNR > GFANA) with a higher affinity for ligand
(24) Xia, Z.; Liu, Y. Biophys. J. 2001, 81, 2395-2402.
(25) Martin-Bermudo, M. D.; Brown, N. H. J. Cell Biol. 1996, 134, 217-226.
FRET )
IDA - a(IAA - cIDD) - d(IDD - bIAA)
xIDDIAA
(1) Figure 1. Schematic of the FRET assay used to study integrin
microclustering. Integrins were expressed along with FRET reporters
containing fluorescent proteins fused to the transmembrane and
cytoplasmic domains of the âPS integrin subunit, dark line (top) or
FRET controls containing fluorescent proteins fused to the trans-
membrane and cytoplasmic domains of CD2, dotted line (bottom). A
monomeric YFP variant and monomeric dsRED variant were used
as the donor and acceptor, respectively.
3144 Analytical Chemistry, Vol. 79, No. 8, April 15, 2007
(Ranaâ) or when the integrins have a â mutation (V409D) with a
higher affinity for ligand (RâB58). This indicates that the FRET
reporters and controls can be used in the FRET assay to study
integrin microclustering without affecting the integrins’ affinity
for ligand, which has been predicted to have an effect on the
integrins’ clustering properties.26
Table 2 shows the calculated FRET results obtained for three
cell lines containing the FRET reporters or controls. All results
have been normalized to the results obtained for the cell line
expressing the FRET reporters and wild-type integrins (TCD-â;
Râ) and correspond to an average value obtained from 100 to 250
cells. The calculated FRET value for each cell was obtained using
the fluorescence images corresponding to the three filter con-
figurations described in the Experimental Section and eq 1. A
FRET value was obtained for each cell by averaging over every
pixel in the image except those pixels corresponding to the nuclear
and perinuclear regions, which were rejected in the measurement.
Cell membrane proteins are processed in the endoplasmic
reticulum, which surrounds the nucleus. A large fluorescence
signal was observed in the perinuclear region that corresponds
to FRET reporters that are not in the cell membrane, and this
interferes with the measurement of integrin clustering in the cell
membrane. To remove this interference from the measurement,
the fluorescence from the nuclear and perinuclear regions was
avoided. It is important to note that a solution-based fluorescence
measurement, such as flow cytometry, would not be able to reject
the internal fluorescence from the cell membrane fluorescence
and would not be useful when measuring the clustering of
membrane proteins labeled with fluorescent proteins. FRET was
measured on cells that were spread to at least 30 ím in diameter,
as the nuclear region could be rejected in these cells. An S2 cell
in solution has a diameter of 10 ím.
Energy transfer is observed for cells containing wild-type
integrins and FRET reporters (TCD-â; Râ), while cells expressing
FRET reporters and no integrins (TCD-â; none) showed no
measurable energy transfer (Table 2). This result indicates that
the clustering of the FRET reporters in cell lines containing
integrins is a result of the integrins and not the FRET reporters
themselves. The cell line expressing the wild-type integrins with
the FRET controls (TCD-CD2; Râ) shows a 50% reduction in the
calculated FRET value compared to the cell line containing the
wild-type integrins and the FRET reporters (TCD-â; Râ). This
confirms the macroscale results that the CD2 transmembrane and
cytoplasmic domains are not as effective at clustering with the
integrins as the FRET reporters.25 The Fo¨rster radius for YFP
and dsRED FRET pairs is 3.14.27 If the donor and acceptor are
separated by more than 5 nm, there is less than 5% efficiency in
energy transfer to the acceptor. Integrin-dependent spreading of
S2 cells results in the FRET reporters being within 5 nm of each
other, using the reasonable assumption that transfer efficiencies
below 5% cannot be detected with our camera system. Considering
energy transfer is measured only in the presence of integrins and
the integrin size,28,29 it is very likely the FRET being measured
using the reporters results from integrin-integrin associations.
To check for macroscale integrin clustering, cells were fixed
with formaldehyde and stained with an antibody against the âPS
integrin subunit after completion of the FRET analysis on live cells.
No significant differences in macroscale integrin clustering were
observed for the cells utilized in this study (Supporting Informa-
tion). In the absence of macroscale differences, the most likely
explanation for the FRET results is that they are reporting on
differences in microscale clustering.
For each experiment and cell line, the average integrin
expression and average fluorescent protein expression were
measured using RPS2C or venus antibodies, respectively. Flow
cytometry was used to obtain an average expression level, and
staining was performed in a surface-sensitive manner (i.e., protein
within the cell was not measured). Shown in Table 3 are the
results for three replicate experiments of RPS2C antibody and YFP
antibody binding to the cell lines utilized in this study. There are
no differences in the expression of RPS2C within the error of the
measurement. There is, however, considerable variation in the
expression of fluorescent protein from one cell line to the next
and from cell to cell within the same cell line. This result was
confirmed using fluorescence microscopy, where the control cell
line (TCD-CD2; Râ) had the highest fluorescence and the cell
line with FRET reporters but no integrins (TCD-â; none) had the
(26) Carman, C. V.; Springer, T. A. Curr. Opin. Cell Biol. 2003, 15, 547-556.
(27) Patterson, G. H.; Piston, D. W.; Barisas, B. G. Anal. Biochem. 2000, 284,
438-440.
(28) Xiong, J.-P.; Stehle, T.; Diefenbach, B.; Zhang, R.; Dunker, D.; Scott, D. L.;
Joachimiak, A.; Goodman, S. L.; Arnaout, M. A. Science 2001, 294, 339-
345.
(29) Xiong, J.-P.; Stehle, T.; Zhang, R.; Joachimiak, A.; Frech, M.; Goodman, S.
L.; Arnaout, M. A. Science 2002, 296, 151-155.
Table 1. Normalized Binding of the rPS2CâPS Integrin
Soluble Binding Ligand Mimetic (TWOW-1) for the
Indicated Seven Cell Lines
cell line
normalized
TWOW-1 binding
Râ 1.0 ( 0.1
TCD-â; Rb 1.1 ( 0.1
TCD-CD2; Râ 1.0 ( 0.1
Ranaâ 2.3 ( 0.3
TCD-â; Ranaâ 2.3 ( 0.1
RâB58 2.3 ( 0.1
TCD-â; RâB58 2.6 ( 0.3
Table 2. Normalized FRET Results for Cells Containing
FRET Reporters (TCD-â) or FRET Controls (TCD-CD2)
and Wild-Type Integrins (râ) or No Integrins
cell line normalized FRET
TCD-â; Râ 1.00 ( 0.07
TCD-CD2; Râ 0.52 ( 0.01
TCD-â; none 0.00 ( 0.00
Table 3. Normalized Binding of rPS2c Antibody and
YFP Antibody to the Indicated Five Cell Lines
cell line
binding of RPS2c
antibody
binding of YFP
antibody
TCD-â; Râ 1.0 ( 0.3 1.0 ( 1.0
TCD-CD2; Rb 0.7 ( 0.2 1.7 ( 0.3
TCD-â; none 0.1 ( 0.1 0.5 ( 0.0
TCD-â; Ranaâ 0.8 ( 0.2 1.3 ( 0.8
TCD-â; RâB58 1.7 ( 0.7 1.0 ( 0.2
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lowest fluorescence. Shown in Figure 2 is a subset of the data
collected from the TCD-â; Râ cell line to determine whether
differences in donor and acceptor expression levels affected the
calculated FRET values. The cherry fluorescence (top, minus the
background signal) and venus fluorescence (middle, minus the
background signal) were measured for a number of cells and
compared to the calculated FRET value (bottom). The results
indicated that there is no correlation between the measured
fluorescence and the calculated FRET value and that differences
in fluorescent protein expression do not preclude a comparison
of the FRET values obtained for the different cell lines. The results
presented in Figure 2 were representative of all the cell lines used
in this study (results not shown).
Mutations that increase the integrins’ affinity for monovalent
ligand may also result in integrin clustering. The FRET assay was
used to measure integrin microclustering for two cell lines
containing mutations that have no effect on macroscale integrin
clustering compared to wild-type integrins (see Supporting Infor-
mation) but have increased ligand binding affinities. The Ranaâ
integrins contain an R cytoplasmic mutation that alters the
integrins conformation in a manner that is thought to mimic inside-
out signaling.4 There is nearly a 2-fold increase in the FRET value
for Ranaâ integrins compared to wild-type integrins, indicating
that there is increased microclustering associated with this
mutation (Table 4). The RâB58 integrins contain an extracellular
mutation in the â subunit which is thought to drive the integrins’
conformation to one that is potentially relevant in outside-in
signaling.4 This mutation is associated with an 3-fold higher level
of FRET than wild-type integrins, indicating these integrins have
increased microclustering compared to both wild-type and Ranaâ
integrins. This FRET value is a lower limit for RâB58 integrins.
S2 cells express endogenous âPS subunits; therefore, the reported
FRET value was a measure of both RâB58 and Râ microclustering.
The results shown in Table 1 indicate that RâB58 integrins are
being expressed in these cells since they have a higher affinity
for TWOW-1 than cells expressing only wild-type integrins.
The results presented here highlight how the developed FRET
assay can be used to study integrin-integrin interactions that are
not observed using standard fluorescence microscopy. Coupling
this technique with well-characterized protein mutants allows
elucidation of the molecular mechanism of integrin clustering. Our
results indicate that both the outside-in signaling conformation
induced by the RâB58 mutation and the inside-out signaling
conformation induced by the Ranaâ mutation increase integrin-
integrin interactions since cells expressing these integrins have
increased FRET values compared to cells expressing wild-type
integrins. Characterization of more mutants is needed to confirm
and extend these preliminary results.
The influence of other membrane proteins in integrin micro-
clustering can also be assessed using the FRET methods
described here. Treatment of the cell surface with proteases prior
to inducing expression of the FRET reporters and the integrins
can be used to test whether other membrane proteins enhance
or reduce integrin microclustering. The FRET reporters and
integrins are re-expressed quickly and at high levels after surface
digestion since they are under the control of an inducible
promoter, while expression of other potential interacting proteins
is reduced or eliminated during the 5-h experiment. It has been
previously demonstrated that protease treatment does not inhibit
ligand binding to wild-type or mutant integrins.4 There is no
significant change in the calculated FRET value for cell lines
expressing wild-type (1.18 ( 0.80 and 1.00 ( 0.07) and Ranaâ
(1.90 ( 0.50 and 2.31 ( 0.01) integrins with and without the
digestion of other cell surface proteins (Table 4). There is,
however, a significant decrease in the FRET value for the cell
line expressing RâB58 integrins. The calculated FRET value for
cells expressing RâB58 integrins was 3.19 ( 1.07 when other
membrane proteins were present, and only 0.74 ( 0.30 after
protease treatment of the cell surface. These results indicate that
there are other membrane proteins that are required for the
increase in integrin microclustering observed with this mutation
and not the Ranaâ mutation. It could be that other membrane
proteins interact directly with the RâB58 conformation to induce
Figure 2. (Top) mdsRED fluorescence intensity; (middle) mYFP
fluorescence intensity; (bottom) calculated FRET value for the cell
line TCD-â; Râ. Each data point in a column represents the same
cell. Background signals were measured by averaging pixel values
where no cells were present, and this value was subtracted from the
mdsRED and mYFP data (top and middle). Data were taken from a
larger set containing 137 cells.
Table 4. Normalized FRET Results for Cells Containing
FRET Reporters (TCD-â) and the Indicated Integrins
cell line
normalized
FRET
normalized FRET
treatmenta
TCD-â; Râ 1.00 ( 0.07 1.18 ( 0.8
TCD-â; Ranaâ 1.90 ( 0.50 2.31 ( 0.01
TCD-â; RâB58 3.19 ( 1.07 0.74 ( 0.30
a Treatment included removal of endogenous integrins through RNA
interference against the myospheroid gene and protease treatment of
cell surface proteins prior to inducing expression of the indicated
integrins and FRET reporters.
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clustering, while only cytoplasmic proteins interact with the Ranaâ
mutation to induce increased integrin microclustering compared
to wild-type integrins.
CONCLUSIONS
Fluorescent proteins attached to the integrin transmembrane/
cytoplasmic domains can be used to measure the microscale
clustering of integrins in live cells using FRET. FRET reporters
generated with a single cloning step can be used to study many
mutant proteins. For example, cloning the FRET reporters can
be completed in 1 week and can be used to screen hundreds of
mutants. If the reporters were cloned directly onto the protein
being studied, 200 cloning steps would be required to study 100
mutants. Considerable time and money can be saved using the
methods reported here. Future work is aimed at generating FRET
reporters that can be used to study the microscale clustering of
other classes of cell membrane proteins. This format is expected
to be generally applicable, with suitable substitution of the
cytoplasmic and transmembrane domains because these domains
are important in the clustering of a number of cell membrane
proteins.30-33 Such studies could deepen our understanding of cell
membrane protein dynamics.
ACKNOWLEDGMENT
This work was supported by a National Institutes of Health
grant (R01 GM42474). E.A.S. was supported by a National
Institutes of Health Training Grant (F32 GM073467) and NIH
Cancer Biology Training Grant (T32 CA09213). The authors thank
Barb Carolus and Debbie Sakiestewa of the Arizona Research
Laboratories Cytometry Service for assistance, Tim Kendall for
assistance in preparing plasmids, Dr. Joyce Schroeder and
colleagues for providing mouse mammary cDNA, Roger Tsien
(Howard Hughes Medical Institute, La Jolla, CA) for dsRED-
mCherry plasmid, and Atsushi Miyawaki (Riken, Wako-city,
Saitama, Japan) for YFP-Venus plasmid.
SUPPORTING INFORMATION AVAILABLE
Complete protein sequences of FRET reporters and FRET
controls; confocal microscope images showing macroscale co-
localization of FRET reporters and integrins; wide-field microscope
images showing lack of integrin macroclusters for all cell lines
used in this study. This material is available free of charge via
the Internet at http://pubs.acs.org.
Received for review October 26, 2006. Accepted January
22, 2007.
AC062008I
(30) Novatchkova, M.; Leibbrandt, A.; Werzowa, J.; Neubuser, A.; Eisenhaber,
F. Trends Biochem. Sci. 2003, 28, 226-229.
(31) Brand, T. Cell Biochem. Biophys. 2005, 43, 95-103.
(32) Sulistijo, E. S.; MacKenzie, K. R. J. Mol. Biol. 2006, 364, 974-990.
(33) Volkmer, T.; Becker, C.; Prodohl, A.; Finger, C.; Schneider, D. Biochem.
Biophys. Acta 2006, 1758, 1815-1822.
Analytical Chemistry, Vol. 79, No. 8, April 15, 2007 3147
